Fluorescent probes are now being used in humans for detection of enzymatic activity in combination with technologies such as optical endomicroscopy (26, 27), and FAP presents an attractive target as there is significant upregulation in NSCLC (28). This evidence concerns the gene FAP and non-small cell lung carcinoma.